S 2477 (Equitable Community Access to Pharmacist Services Act) expands Medicare Part B coverage to include specific pharmacist services previously only covered when provided by physicians. It directly affects Medicare beneficiaries and pharmacists by allowing coverage for services like evaluating patients for COVID-19, flu, or respiratory illnesses, and addressing public health emergencies - provided pharmacists are licensed or operating under federal emergency authority. The bill establishes payment at 80% of the lesser of actual charge or 85% of physician payment rates (100% during federal emergencies) and prohibits balance billing for these services. It also clarifies that existing Medicare enrollment pathways for pharmacists remain available. This bill modifies Medicare Part B coverage under the Social Security Act without restricting current pharmacy reimbursement options.
This bill modifies Medicare Part D drug coverage to limit out-of-pocket costs for seniors taking certain long-term medications. It directly affects Medicare beneficiaries using "chronic care drugs" (like diabetes medications, blood thinners, and asthma inhalers) under Part D plans. Starting in 2025, the bill caps cost-sharing: below the deductible, seniors pay no more than the drug's negotiated price after discounts; above the deductible but below the out-of-pocket limit, coinsurance is based on that same negotiated price (not list price). Fixed copays for these drugs are exempt from this rule.
This bill authorizes the U.S. President to negotiate a tax agreement with Taiwan through the American Institute in Taiwan (AIT). It would create a formal tax treaty to prevent double taxation and reduce tax evasion for U.S. businesses and taxpayers operating with Taiwan, directly benefiting companies engaged in cross-border trade and investment. The agreement must follow standard U.S. tax convention rules (like the 2016 Model Convention) and requires congressional approval via a specific concurrent resolution before taking effect. The bill does not finalize the treaty but establishes the process for negotiation and U.S. approval.
This bill (S 1396) amends the Small Business Act to improve commercialization outcomes for small businesses participating in the SBIR and STTR programs. It requires federal agencies to include commercialization likelihood and add at least one commercialization expert to peer reviews, shortens review timelines from 1 year to 180 days, and mandates each agency to appoint a Technology Commercialization Official to assist awardees. The bill also establishes a new annual "commercialization impact assessment" to track metrics like sales, outside investment, patents, and spin-out companies from SBIR/STTR projects. These changes directly affect small business innovators receiving SBIR/STTR grants and the federal agencies managing these programs.
The Peace Corps Reauthorization Act of 2023 (S 1203) authorizes $410.5 million annually for Peace Corps operations through fiscal year 2028 and includes numerous provisions to improve volunteer support and program operations. Key changes include increasing readjustment allowances for volunteers from $125 to $375, extending health care coverage for returning volunteers, and establishing a comprehensive zero-tolerance drug policy for volunteers. The bill also codifies special hiring preferences for returning volunteers in federal positions, creates new protections against retaliation for volunteers reporting issues, and requires the Peace Corps to develop strategies for expanding volunteer presence in Oceania. These provisions directly affect Peace Corps volunteers, returning volunteers, and Peace Corps staff by enhancing support systems and program operations.
S 936 amends the Small Business Act to integrate career and technical education (CTE) into small business support programs. It requires Small Business Development Centers (SBDCs) and Women’s Business Centers (WBCs) to help small businesses hire CTE program graduates and assist CTE graduates in starting businesses. The bill defines "career and technical education" using the Perkins Act standard and adds specific new service requirements to existing SBDC and WBC programs. This directly affects small businesses seeking talent and CTE students/graduates aiming to launch ventures, with no new funding or tax changes.
The International Children with Disabilities Protection Act of 2023 establishes a U.S. government program to support organizations working to keep children with disabilities in family settings rather than residential institutions worldwide. The program provides grants to nongovernmental organizations with disability rights expertise, prioritizing those working in countries with large populations of children in residential care. It funds capacity-building efforts to develop disability leaders, provides training on successful family inclusion models, and creates online programs to share best practices globally. The bill requires annual briefings and triennial reports to Congress on the program's implementation, with funding authorized at $2 million for 2024 and $10 million annually through 2029. This legislation aims to advance policies that ensure children with disabilities grow up with their families and transition to independent living as adults.
This bill requires the U.S. President to annually certify whether Hong Kong Economic and Trade Offices (HKETOs) in the U.S. deserve diplomatic privileges (like immunity from local laws). If the President certifies they no longer merit these privileges, HKETOs must close within 180 days. It also mandates that U.S. government agencies seeking partnerships with HKETOs must first obtain a certification confirming such agreements don’t promote Chinese efforts to undermine Hong Kong’s autonomy. Congress can block a certification within 90 days using a disapproval resolution, which would require expedited Senate and House procedures. The bill directly affects HKETOs operating in the U.S. and U.S. agencies engaging with them.
HR 4893, the Scientific Integrity Act, requires federal agencies that fund, conduct, or oversee scientific research to adopt policies preventing political interference in science. The bill mandates these agencies to prohibit suppression or distortion of research findings, establish Scientific Integrity Officers to enforce policies, and implement training and reporting systems. It directly affects scientists and engineers employed by or contracted with covered agencies (like the EPA or NIH), ensuring their work remains free from political pressure. Key mechanisms include annual public reporting on misconduct complaints, whistleblower protections, and requiring scientific conclusions to be based on evidence, not ideology.
HR 4889, the Raise the Wage Act of 2023, would gradually increase the federal minimum wage for most workers to $15.50 per hour by 2027, with specific annual targets: $9.50 starting in 2023, rising to $11.00 after one year, $12.50 after two years, and $15.50 after four years. It would also phase out the separate lower minimum wage for tipped employees (starting at $6.00/hour) by aligning their pay with the regular minimum wage by 2028, while requiring employers to let workers keep all tips. The bill includes similar phased increases for workers under 20 and transitions toward fairer wages for workers with disabilities under special certificates, which would sunset after 2028. Future annual increases after 2028 would tie the minimum wage to the median hourly wage of all workers.
HR 4157, the "Not Just a Number Act," requires the Department of Veterans Affairs (VA) to produce annual reports on veteran suicide rates and their connection to VA healthcare and benefits. The reports must break down suicide rates by age, gender, and race, and examine how engagement with VA services (like Vet Centers, healthcare enrollment, benefits claims, and housing loans) correlates with suicide trends. The bill also mandates a VA toolkit for state/local coroners to improve veteran suicide death reporting, and a study on creating a dedicated VA suicide prevention office. These measures aim to standardize data collection and identify effective prevention strategies, directly affecting VA operations, congressional oversight, and veteran care systems.
The SWIFT Detection Act of 2023 amends federal health laws to allow states, localities, and tribes to use public health grants for wastewater testing to track trends in controlled substance use, provided evidence shows this method is effective. It also establishes a pilot program for public health laboratories to partner with public, private, and academic entities to detect fentanyl and similar synthetic opioids through wastewater analysis. The bill directly affects community health agencies and labs by adding wastewater surveillance as a tool for monitoring drug trends, without changing drug laws or treatment requirements. It focuses on data collection to inform public health responses to opioid use.
